Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current research in otosclerosis.

Konstantina M Stankovic1, Michael J McKenna

  • 1Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114-3096, USA.

Current Opinion in Otolaryngology & Head and Neck Surgery
|September 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-2 Transferrin May Not Be Specific for Presence of Cerebrospinal Fluid in Middle Ear Fluid.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Engineering of functional auditory neurons from human induced pluripotent stem cells.

Military Medical Research·2026
Same author

A plasma metabolomic fingerprint of moderate or severe hearing loss.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation.

Theranostics·2026
Same author

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Nature communications·2026
Same author

Genetic Diagnosis and Discovery Enabled by Large Language Models.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Photon-counting detector computed tomography for temporal bone: does higher resolution matter?

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Advances in patient-specific 3D-printed models in temporal bone surgery.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Graduated autonomy in head and neck microvascular surgery fellowship training: oncologic and reconstructive competency, safety, and educational implications.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Costs and system-wide considerations within head and neck reconstruction: moving toward a value-based care framework.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Modern methods of dorsal augmentation rhinoplasty.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Flap selection for circumferential pharyngeal reconstruction.

Current opinion in otolaryngology & head and neck surgery·2026
See all related articles

Otosclerosis research reveals genetic heterogeneity and the role of osteoprotegerin and measles virus in this common cause of hearing loss. Understanding these mechanisms may lead to new treatments for otosclerosis.

Area of Science:

  • Otolaryngology
  • Genetics
  • Pathology

Background:

  • Otosclerosis is a common cause of acquired hearing loss, affecting the human temporal bone.
  • It has a hereditary predisposition, indicating a genetic component to the disorder.

Purpose of the Study:

  • To summarize current research advances in otosclerosis.
  • To provide historical context for these research findings.

Main Methods:

  • Review of genetic studies identifying multiple genes and chromosomal loci associated with otosclerosis.
  • Analysis of osteoprotegerin expression in the otic capsule and cochlea.
  • Utilizing osteoprotegerin knockout mice as an animal model.
  • Investigating the potential role of measles virus in otosclerosis pathogenesis.

Related Experiment Videos

  • Employing quantitative measures of angiogenesis.

    • Main Results:

    • Otosclerosis is genetically heterogeneous, with at least seven genes linked to six chromosomal loci.
    • High osteoprotegerin expression in normal otic capsules suggests a mechanism inhibiting remodeling.
    • Osteoprotegerin knockout mice mimic otosclerosis-like abnormal remodeling.
    • Evidence suggests a role for measles virus in otosclerosis, though mechanisms are unclear.
    • Angiogenesis measures can differentiate clinical and histological otosclerosis.

    Conclusions:

    • Understanding molecular mechanisms inhibiting normal otic capsule remodeling is key.
    • Identifying dysregulation of these mechanisms in otosclerosis is crucial.
    • Future rational treatment strategies for otosclerosis can be designed based on these insights.